B lineage-specific regulation of V(D)J recombinase activity is established in common lymphoid progenitors

被引:95
作者
Borghesi, L
Hsu, LY
Miller, JP
Anderson, M
Herzenberg, L
Herzenberg, L
Schlissel, MS
Allman, D
Gerstein, RM
机构
[1] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA
[2] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA
[3] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[4] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA
关键词
B lymphopoiesis; V(D)J recombination; lineage restriction; hematopoiesis; stem cell; transcription;
D O I
10.1084/jem.20031800
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Expression of V(D)J recombinase activity in developing lymphocytes is absolutely required for initiation of V(D)J recombination at antigen receptor loci. However, little is known about when during hematopoietic development the V(D)J recombinase is first active, nor is it known what elements activate the recombinase in multipotent hematopoietic progenitors. Using mice that express a fluorescent transgenic V(D)J recombination reporter, we show that the V(D)J recombinase is active as early as common lymphoid progenitors (CLPs) but not in the upstream progenitors that retain myeloid lineage potential. Evidence of this recombinase activity is detectable in all four progeny lineages (B, T, and NK, and DC), and rag2 levels are the highest in progenitor subsets immediately downstream of the CLP. By single cell PCR, we demonstrate that V(D)J rearrangements are detectable at IgH loci in similar to5% of splenic natural killer cells. Finally, we show that recombinase activity in CLPs is largely controlled by the Erag enhancer. As activity of the Erag enhancer is restricted to the B cell lineage, this provides the first molecular evidence for establishment of a lineage-specific transcription program in multipotent progenitors.
引用
收藏
页码:491 / 502
页数:12
相关论文
共 65 条
[51]   Complementation of V(D)J recombination deficiency in RAG-1(-/-) B cells reveals a requirement for novel elements in the N-terminus of RAG-1 [J].
Roman, CAJ ;
Cherry, SR ;
Baltimore, D .
IMMUNITY, 1997, 7 (01) :13-24
[52]  
Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO
[53]  
2-M
[54]   Overlapping signals for protein degradation and nuclear localization define a role for intrinsic RAG-2 nuclear uptake in dividing cells [J].
Ross, AE ;
Vuica, M ;
Desiderio, S .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (15) :5308-5319
[55]   Lineage plasticity and commitment in T-cell development [J].
Rothenberg, EV ;
Dionne, CJ .
IMMUNOLOGICAL REVIEWS, 2002, 187 :96-115
[56]   Cytotoxic/natural killer cell cutaneous lymphomas -: Report of the EORTC Cutaneous Lymphoma Task Force Workshop [J].
Santucci, M ;
Pimpinelli, N ;
Massi, D ;
Kadin, ME ;
Meijer, CJLM ;
Müller-Hermelink, HK ;
Paulli, M ;
Wechsler, J ;
Willemze, R ;
Audring, H ;
Bernengo, MG ;
Cerroni, L ;
Chimenti, S ;
Chott, A ;
Díaz-Pérez, JL ;
Dippel, E ;
Duncan, LM ;
Feller, AC ;
Geerts, ML ;
Hallermann, C ;
Kempf, W ;
Russell-Jones, R ;
Sander, C ;
Berti, E .
CANCER, 2003, 97 (03) :610-627
[57]   THE V(D)J RECOMBINATION ACTIVATING GENE, RAG-1 [J].
SCHATZ, DG ;
OETTINGER, MA ;
BALTIMORE, D .
CELL, 1989, 59 (06) :1035-1048
[58]   RAG-2-DEFICIENT MICE LACK MATURE LYMPHOCYTES OWING TO INABILITY TO INITIATE V(D)J REARRANGEMENT [J].
SHINKAI, Y ;
RATHBUN, G ;
LAM, KP ;
OLTZ, EM ;
STEWART, V ;
MENDELSOHN, M ;
CHARRON, J ;
DATTA, M ;
YOUNG, F ;
STALL, AM ;
ALT, FW .
CELL, 1992, 68 (05) :855-867
[59]  
Sikes ML, 1999, MOL CELL BIOL, V19, P2773
[60]   Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity [J].
Taccioli, GE ;
Amatucci, AG ;
Beamish, HJ ;
Gell, D ;
Xiang, XH ;
Arzayus, MIT ;
Priestley, A ;
Jackson, SP ;
Rothstein, AM ;
Jeggo, PA ;
Herrera, VLM .
IMMUNITY, 1998, 9 (03) :355-366